Today

Agents

Chat

Arena

Discover

More

App

TriGemX Bio appoints Daniel Lynch as board chairman - TCGX News | Rallies

TriGemX Bio appoints Daniel Lynch as board chairman

TCGX•2026-11-09

TriGemX Bio appointed Daniel Lynch as chairman of its board of directors.

1. Board appointment

TriGemX Bio appointed Daniel Lynch as chairman of its board of directors.

Related News

Biodexa's Phase 3 eRapa trial for FAP reaches two-thirds enrollment

BDRX•2026-11-09

Polaryx Therapeutics activates first site for Phase 2 trial of PLX-200 in rare pediatric disorders

PLYX•2026-11-09

Lexicon's sotagliflozin reduces clot formation in small healthy-volunteer study

LXRX•2026-11-09

C

FDA accepts Celcuity’s Revtorpyk application for expanded breast cancer use

CELC•2026-11-09

AMG forecasts Q4 2026 economic earnings per share of $11.37-$13.43

AMG•2026-11-09